3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Terminated
1
Recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Neoplasms
4
Melanoma
2
Uterine Cervical Neoplasms
1
Solid Tumor, Adult
1
Skin Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Neuromyelitis Optica
1
Neoplasms, Second Primary
1
Neoplasm Metastasis
1
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
1
Myasthenia Gravis
1
Multiple Sclerosis
1
Lung Neoplasms
1
Laryngectomy; Status
1
Hematologic Neoplasms
1
Hematologic Diseases
1
Endometrial Neoplasms
1
Encephalomyelitis, Acute Disseminated
1
Carcinoma, Renal Cell
1
COVID-19
1
Breast Neoplasms
1
Autoimmune Diseases of the Nervous System
1
Interventions
Docetaxel
21
Radiosurgery
19
Radiotherapy
17
Androgen Antagonists
14
Leuprolide
11
Goserelin
11
bicalutamide
9
enzalutamide
8
Surveys and Questionnaires
8
Prednisone
8
Brachytherapy
8
Blood Specimen Collection
8
Abiraterone Acetate
8
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
7
Radiotherapy, Intensity-Modulated
7
Multiparametric Magnetic Resonance Imaging
7
Gonadotropin-Releasing Hormone
7
Triptorelin Pamoate
6
pembrolizumab
4
cabazitaxel
4
abiraterone
4
Standard of Care
4
Positron Emission Tomography Computed Tomography
4
Metformin
4
Heavy Ion Radiotherapy
4
Exercise
4
Estramustine
4
luprolide acetate gel depot
3
darolutamide
3
Watchful Waiting
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Prostatic Neoplasms
×
Data Collection
×
Clear all
NCT05612841
2022-11-10
IN-PROVE
Centre Hospitalier Universitaire de Besancon
Unknown
264 enrolled